Lacrisert
Product Images NDC 24208-800

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacrisert (NDC 24208-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton.jpg (Carton)

Flat packaging label for Lacrisert 5 mg hydroxypropyl cellulose ophthalmic inserts. The label indicates Rx only and highlights 60 sterile ophthalmic inserts per container. Distributed by Bausch + Lomb, with no preservative in the product. The label also notes inclusion of two sterile applicators and a storage container. The design features blue gradient color blocks and a barcode.*

FDA Label Image

Chemical Structure (Lacrisert 01)

Chemical structure diagram depicting the repeating unit of the active ingredient in Lacrisert. The structure shows two sugar rings connected by oxygen atoms, with various hydroxyl (OH) groups and a side chain where R is specified as CH2CHCH3 with an attached hydroxyl group (OH).*

FDA Label Image

Figure (Lacrisert 02)

An instructional illustration showing a hand opening a small, single-use packaging containing a round Lacrisert insert. The image depicts how to peel open the blister pack to remove the insert for administration, relevant to Lacrisert by Bausch & Lomb Incorporated.*

FDA Label Image

Figure (Lacrisert 03)

An instructional black-and-white line drawing showing a hand holding and preparing to insert a small rectangular solid, likely representing a Lacrisert ocular insert. The fingers are pinching the insert, demonstrating how to handle the product before application.*

FDA Label Image

Figure (Lacrisert 04)

An instructional line drawing showing a hand placing a small cylindrical insert into the lower eyelid, demonstrating the method of administration for Lacrisert ophthalmic insert.*

FDA Label Image

Figure (Lacrisert 05)

An instructional line drawing showing a hand inserting a small round object into the lower eyelid of an eye. The illustration likely demonstrates the proper placement of Lacrisert, consistent with its use as an ocular insert.*

FDA Label Image

Figure (Lacrisert 06)

An instructional diagram showing a finger placing a Lacrisert insert into the lower eyelid, demonstrating the proper method of ocular insert administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.